Reviews

< Previous         Next >  
DCAF1 (VprBP): emerging physiological roles for a unique dual-service E3 ubiquitin ligase substrate receptor
N. Max Schabla 1,2 , Koushik Mondal 1,3 , and Patrick C. Swanson 1,*
1 Department of Medical Microbiology and Immunology, Creighton University, 2500 California Plaza, Omaha, NE 68178, USA
2 Present address: Institute of Cellular and Molecular Immunology, Georg-August-University of Go¨ttingen, Medical Faculty, Humboldtallee 34, 37073 Go¨ttingen, Germany
3 Present address: Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Sciences Center, 930 Madison Avenue, Memphis, TN 38163, USA
*Correspondence to:Patrick C. Swanson, E-mail: pswanson@creighton.edu
J Mol Cell Biol, Volume 11, Issue 9, September 2019, 725-735,  https://doi.org/10.1093/jmcb/mjy085
Keyword: V(D)J recombination, Merlin, Dicer, p53, EDD/DYRK2, TET, Hippo
Cullin-RING ligases (CRLs) comprise a large group of modular eukaryotic E3 ubiquitin ligases. Within this family, the CRL4 ligase (consisting of the Cullin4 [CUL4] scaffold protein, the Rbx1 RING finger domain protein, the DNA damage-binding protein 1 [DDB1], and one of many DDB1-associated substrate receptor proteins) has been intensively studied in recent years due to its involvement in regulating various cellular processes, its role in cancer development and progression, and its subversion by viral accessory proteins. Initially discovered as a target for hijacking by the human immunodeficiency virus accessory protein r, the normal targets and function of the CRL4 substrate receptor protein DDB1–Cul4-associated factor 1 (DCAF1; also known as VprBP) had remained elusive, but newer studies have begun to shed light on these questions. Here, we review recent progress in understanding the diverse physiological roles of this DCAF1 in supporting various general and cell type-specific cellular processes in its context with the CRL4 E3 ligase, as well as another HECT-type E3 ligase with which DCAF1 also associates, called EDD/UBR5. We also discuss emerging questions and areas of future study to uncover the dynamic roles of DCAF1 in normal physiology.